CATX: Perspective Therapeutics Inc
CATX exchange rate has changed by 3.40% for today. During the day, the instrument was traded at a low of 2.25 and at a high of 2.46.
Follow Perspective Therapeutics Inc dynamics. Real-time quotes will help you quickly react to market changes. By switching between different timeframes, you can monitor exchange rate trends and dynamics by minutes, hours, days, weeks, and months. Use this information to forecast market changes and to make informed trading decisions.
- M5
- M15
- M30
- H1
- H4
- D1
- W1
- MN
CATX News
- Perspective Therapeutics, Inc. (CATX) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
- UBS lowers Perspective Therapeutics stock price target on competition concerns
- Perspective Therapeutics, Inc. (CATX) Presents at UBS Global Healthcare Conference 2025 Transcript
- Oppenheimer lowers Perspective Therapeutics stock price target on competitive data
- Perspective Therapeutics earnings missed by $0.03, revenue topped estimates
- Stevanato Group (STVN) Q3 Earnings and Revenues Surpass Estimates
- Rigel Pharmaceuticals (RIGL) Tops Q3 Earnings and Revenue Estimates
- Ionis Pharmaceuticals (IONS) Reports Q3 Loss, Beats Revenue Estimates
- Perspective Therapeutics stock falls after updated cancer drug trial data
- Salesforce, Oracle among Monday’s market cap stock movers
- Mega-cap movers Apple and Oracle lead Monday’s market cap stock shifts
- BTIG initiates coverage on Perspective Therapeutics stock with Buy rating
- This Aptiv Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday - Perspective Therapeutics (AMEX:CATX), Aptiv (NYSE:APTV)
- 3 Best Stocks to Buy Now, 9/11/2025, According to Top Analysts - TipRanks.com
- Perspective Therapeutics stock holds Buy rating at UBS ahead of ESMO data
- Oppenheimer lowers Perspective Therapeutics stock price target to $14
- Perspective Therapeutics earnings matched, revenue topped estimates
- Durect (DRRX) Reports Q2 Loss, Tops Revenue Estimates
- electroCore, Inc. (ECOR) Reports Q2 Loss, Tops Revenue Estimates
- Amneal Pharmaceuticals (AMRX) Q2 Earnings Top Estimates
Frequently Asked Questions
What is CATX stock price today?
Perspective Therapeutics Inc stock is priced at 2.43 today. It trades within 2.25 - 2.46, yesterday's close was 2.35, and trading volume reached 1441. The live price chart of CATX shows these updates.
Does Perspective Therapeutics Inc stock pay dividends?
Perspective Therapeutics Inc is currently valued at 2.43. Dividend policy depends on the company, while investors also watch -28.74% and USD. View the chart live to track CATX movements.
How to buy CATX stock?
You can buy Perspective Therapeutics Inc shares at the current price of 2.43. Orders are usually placed near 2.43 or 2.73, while 1441 and 2.53% show market activity. Follow CATX updates on the live chart today.
How to invest into CATX stock?
Investing in Perspective Therapeutics Inc involves considering the yearly range 1.60 - 5.39 and current price 2.43. Many compare -11.64% and -35.71% before placing orders at 2.43 or 2.73. Explore the CATX price chart live with daily changes.
What are Perspective Therapeutics Inc stock highest prices?
The highest price of Perspective Therapeutics Inc in the past year was 5.39. Within 1.60 - 5.39, the stock fluctuated notably, and comparing with 2.35 helps spot resistance levels. Track Perspective Therapeutics Inc performance using the live chart.
What are Perspective Therapeutics Inc stock lowest prices?
The lowest price of Perspective Therapeutics Inc (CATX) over the year was 1.60. Comparing it with the current 2.43 and 1.60 - 5.39 shows potential long-term entry points. Watch CATX moves on the chart live for more details.
When did CATX stock split?
Perspective Therapeutics Inc has gone through stock splits historically. These changes are visible in , 2.35, and -28.74% after corporate actions.
- Previous Close
- 2.35
- Open
- 2.37
- Bid
- 2.43
- Ask
- 2.73
- Low
- 2.25
- High
- 2.46
- Volume
- 1.441 K
- Daily Change
- 3.40%
- Month Change
- -11.64%
- 6 Months Change
- -35.71%
- Year Change
- -28.74%
- Act
- Fcst
- Prev
- Act
- Fcst
- Prev
- Act
- Fcst
- 0.0%
- Prev
- 0.2%
- Act
- Fcst
- Prev
- Act
- Fcst
- Prev
- 4.798%